These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10780327)

  • 21. Thrombin-induced phosphorylation of the regulatory light chain of myosin II in cultured bovine corneal endothelial cells.
    Satpathy M; Gallagher P; Lizotte-Waniewski M; Srinivas SP
    Exp Eye Res; 2004 Oct; 79(4):477-86. PubMed ID: 15381032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
    Burke FM; Warnock M; Schmaier AH; Mosberg HI
    Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombin-induced IL-6 production in human synovial fibroblasts is mediated by PAR1, phospholipase C, protein kinase C alpha, c-Src, NF-kappa B and p300 pathway.
    Chiu YC; Fong YC; Lai CH; Hung CH; Hsu HC; Lee TS; Yang RS; Fu WM; Tang CH
    Mol Immunol; 2008 Mar; 45(6):1587-99. PubMed ID: 18062909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rho-kinase is involved in the sustained phosphorylation of myosin and the irreversible platelet aggregation induced by PAR1 activating peptide.
    Missy K; Plantavid M; Pacaud P; Viala C; Chap H; Payrastre B
    Thromb Haemost; 2001 Mar; 85(3):514-20. PubMed ID: 11307824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
    Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
    Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential activation and inhibition of human platelet thrombin receptors by structurally distinct alpha-, beta- and gamma-thrombin.
    Soslau G; Goldenberg SJ; Class R; Jameson B
    Platelets; 2004 May; 15(3):155-66. PubMed ID: 15203717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shutoff and agonist-triggered internalization of protease-activated receptor 1 can be separated by mutation of putative phosphorylation sites in the cytoplasmic tail.
    Hammes SR; Shapiro MJ; Coughlin SR
    Biochemistry; 1999 Jul; 38(29):9308-16. PubMed ID: 10413505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of the thrombin receptor (PAR-1) N-terminus from the surface of human platelets activated by thrombin.
    Ramachandran R; Klufas AS; Molino M; Ahuja M; Hoxie JA; Brass LF
    Thromb Haemost; 1997 Sep; 78(3):1119-24. PubMed ID: 9308764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.
    Chen WF; Lee JJ; Chang CC; Lin KH; Wang SH; Sheu JR
    Haematologica; 2013 May; 98(5):793-801. PubMed ID: 23065519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors.
    Altrogge LM; Monard D
    Anal Biochem; 2000 Jan; 277(1):33-45. PubMed ID: 10610687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
    Leger AJ; Jacques SL; Badar J; Kaneider NC; Derian CK; Andrade-Gordon P; Covic L; Kuliopulos A
    Circulation; 2006 Mar; 113(9):1244-54. PubMed ID: 16505172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets.
    Nylander M; Osman A; Ramström S; Aklint E; Larsson A; Lindahl TL
    Thromb Res; 2012 Apr; 129(4):e51-8. PubMed ID: 22283974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
    Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
    Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets.
    Fälker K; Haglund L; Gunnarsson P; Nylander M; Lindahl TL; Grenegård M
    Biochem J; 2011 Jun; 436(2):469-80. PubMed ID: 21391917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acceleration of Ca2+ ionophore-induced arachidonic acid liberation by thrombin without the proteolytic action toward the receptor in human platelets.
    Akiba S; Kawauchi T; Sato T
    Eur J Biochem; 1999 Feb; 259(3):643-50. PubMed ID: 10092848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PAR3 is a cofactor for PAR4 activation by thrombin.
    Nakanishi-Matsui M; Zheng YW; Sulciner DJ; Weiss EJ; Ludeman MJ; Coughlin SR
    Nature; 2000 Apr; 404(6778):609-13. PubMed ID: 10766244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans.
    Reiter R; Derhaschnig U; Spiel A; Keen P; Cardona F; Mayr F; Jilma B
    Thromb Haemost; 2003 Nov; 90(5):898-903. PubMed ID: 14597986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annexin V binding to platelets is agonist, time and temperature dependent.
    Ramstrom S; O'Neill S; Dunne E; Kenny D
    Platelets; 2010; 21(4):289-96. PubMed ID: 20230207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1.
    Poullis M; Manning R; Laffan M; Haskard DO; Taylor KM; Landis RC
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):370-8. PubMed ID: 10917956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.
    Duvernay M; Young S; Gailani D; Schoenecker J; Hamm HE
    Mol Pharmacol; 2013 Apr; 83(4):781-92. PubMed ID: 23307185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.